ArticleFrontiers in immunology2026

A composite biomarker based on early dynamic changes in lactate dehydrogenase and PD-L1 expression enhances outcome prediction for immunochemotherapy in HER2-negative advanced gastric cancer.

Yue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.